Autocrine fibroblast growth factor 18 mediates dexamethasone-induced osteogenic differentiation of murine mesenchymal stem cells

Journal of Cellular Physiology

Volumn 224, Issue 2, 2010, Pages 509-515

  Hamidouche, Zahia ^a,b   Fromigué, Olivia ^a,b   Nuber, Ulrike ^c   Vaudin, Pascal ^d,e   Pages, Jean Christophe ^d,e   Ebert, Regina ^f   Jakob, Franz ^f   Miraoui, Hichem ^a,b   Marie, Pierre J ^a,b  

^a HÔPITAL LARIBOISIÈRE   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c LUND UNIVERSITY   (Sweden)

^d INSERM   (France)

^e UNIVERSITÉ DE TOURS   (France)

^f UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; DEXAMETHASONE; FIBROBLAST GROWTH FACTOR 18; FIBROBLAST GROWTH FACTOR RECEPTOR 1; FIBROBLAST GROWTH FACTOR RECEPTOR 2; MITOGEN ACTIVATED PROTEIN KINASE 1; PHOSPHATIDYLINOSITOL 3 KINASE; SHORT HAIRPIN RNA; FIBROBLAST GROWTH FACTOR; MITOGEN ACTIVATED PROTEIN KINASE;

ANIMAL CELL; ARTICLE; AUTOCRINE EFFECT; CELL DIFFERENTIATION; CELL LYSATE; DOWN REGULATION; GENE EXPRESSION; IMMUNOBLOTTING; LENTIVIRUS INFECTION; MESENCHYMAL STEM CELL; MICROARRAY ANALYSIS; NONHUMAN; OSTEOBLAST; PHENOTYPE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ANIMAL; BIOLOGICAL MODEL; BONE DEVELOPMENT; CELL LINE; CYTOLOGY; DRUG EFFECT; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENE SILENCING; GENETICS; METABOLISM; MOUSE; SIGNAL TRANSDUCTION; UPREGULATION;

MURINAE;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; AUTOCRINE COMMUNICATION; CELL DIFFERENTIATION; CELL LINE; DEXAMETHASONE; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FIBROBLAST GROWTH FACTORS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENE SILENCING; MESENCHYMAL STEM CELLS; MICE; MODELS, BIOLOGICAL; OSTEOGENESIS; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 1; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 2; SIGNAL TRANSDUCTION; UP-REGULATION;

EID: 77953632883     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.22152     Document Type: Article

References (41)

1. Baksh D, Tuan RS. 2007. Canonical and non-canonical Wnts differentially affect the development potential of primary isolate of human bone marrowmesenchymal stem cells. J Cell Physiol 212:817-826. (Pubitemid 47267551)
2. Beak JY, Kang HS, Kim YS, Jetten AM. 2007. Kruppel-like zinc finger protein Glis3 promotes osteoblast differentiation by regulating FGF18 expression. J Bone Miner Res 22:1234-1244.
3. Bennett CN, Longo KA, Wright WS, Suva LJ, Lane TF, Hankenson KD, MacDougald OA. 2005. Regulation of osteoblastogenesis and bone mass by Wnt10b. Proc Natl Acad Sci USA 102:3324-3329.
4. Bianco P, Riminucci M, Gronthos S, Robey PG. 2001. Bone marrow stromal stem cells: Nature, biology, and potential applications. Stem Cells 19:180-192. (Pubitemid 32524539)
5. Cheng SL, Yang JW, Rifas L, Zhang SF, Avioli LV. 1994. Differentiation of human bone marrow osteogenic stromal cells in vitro: Induction of the osteoblast phenotype by dexamethasone. Endocrinology 134:277-286. (Pubitemid 24021999)
6. Dailey L, Ambrosetti D, Mansukhani A, Basilico C. 2005. Mechanisms underlying differential responses to FGF signaling. Cytokine Growth Factor Rev 16:233-247. (Pubitemid 40616120)
7. Davidson D, Blanc A, Filion D, Wang H, Plut P, Pfeffer G, Buschmann MD, Henderson JE. 2005. Fibroblast growth factor (FGF) 18 signals through FGF receptor 3 to promote chondrogenesis. J Biol Chem 280:20509-20515. (Pubitemid 40776751)
8. Dennis JE, Merriam A, Awadallah A, Yoo JU, Johnstone B, Caplan AI. 1999. A quadripotential mesenchymal progenitor cell isolated from the marrow of an adult mouse. J Bone Miner Res 14:700-709. (Pubitemid 29210596)
9. Eswarakumar VP, Lax I, Schlessinger J. 2005. Cellular signaling by fibroblast growth factor receptors. Cytokine Growth Factor Rev 16:139-149. (Pubitemid 40616112)
10. Etheridge SL, Spencer GJ, Heath DJ, Genever PG. 2004. Expression profiling and functional analysis of wnt signaling mechanisms in mesenchymal stem cells. Stem Cells 22:849-860.
11. Fromigue O, Marie PJ, Lomri A. 1997. Differential effects of transforming growth factor beta2, dexamethasone and 1,25-dihydroxyvitamin D on human bone marrow stromal cells. Cytokine 9:613-623.
12. Fromigue O, Hamidouche Z, Chateauvieux S, Charbord P, Marie PJ. 2008. Distinct osteoblastic differentiation potential of murine fetal liver and bone marrow stroma-derived mesenchymal stem cells. J Cell Biochem 104:620-628.
13. Fujita T, Azuma Y, Fukuyama R, Hattori Y, Yoshida C, Koida M, Ogita K, Komori T. 2004. Runx2 induces osteoblast and chondrocyte differentiation and enhances theirmigration by coupling with PI3K-Akt signaling. J Cell Biol 166:85-95.
14. Gaur T, Lengner CJ, Hovhannisyan H, Bhat RA, Bodine PV, Komm BS, Javed A, van Wijnen AJ, Stein JL, Stein GS, Lian JB. 2005. Canonical WNT signaling promotes osteogenesis by directly stimulating Runx2 gene expression. J Biol Chem 280:33132-33140.
15. Ge C, Xiao G, Jiang D, Franceschi RT. 2007. Critical role of the extracellular signal-regulated kinase-MAPK pathway in osteoblast differentiation and skeletal development. J Cell Biol 176:709-718.
16. Gori F, Thomas T,Hicok KC, Spelsberg TC, Riggs BL. 1999. Differentiation of human marrow stromal precursor cells: Bone morphogenetic protein-2 increases OSF2/CBFA1, enhances osteoblast commitment, and inhibits late adipocytematuration. J Bone Miner Res 14:1522-1535.
17. Gowen LC, Petersen DN, Mansolf AL, Qi H, Stock JL, Tkalcevic GT, Simmons HA, Crawford DT, Chidsey-Frink KL, Ke HZ, McNeish JD, Brown TA. 2003. Targeted disruption of the osteoblast/osteocyte factor 45 gene (OF45) results in increased bone formation and bone mass. J Biol Chem 278:1998-2007.
18. Gregory CA, Gunn WG, Reyes E, Smolarz AJ, Munoz J, Spees JL, Prockop DJ. 2005.How Wnt signaling affects bone repair by mesenchymal stem cells from the bone marrow. Ann NY Acad Sci 1049:97-106.
19. Gurok U, Steinhoff C, Lipkowitz B, Ropers HH, Scharff C, Nuber UA. 2004. Gene expression changes in the course of neural progenitor cell differentiation. J Neurosci 24:5982-6002.
20. Hamidouche Z, Hay E, Vaudin P, Charbord P, Schule R, Marie PJ, Fromigue O. 2008. FHL2 mediates dexamethasone-induced mesenchymal cell differentiation into osteoblasts by activating Wnt/{beta}-catenin signaling-dependent Runx2 expression. FASEB J 22:3813-3822.
21. Hinoi E, Bialek P, Chen YT, Rached MT, Groner Y, Behringer RR, Ornitz DM, Karsenty G. 2006. Runx2 inhibits chondrocyte proliferation and hypertrophy through its expression in the perichondrium. Genes Dev 20:2937-2942.
22. Jaiswal RK, Jaiswal N, Bruder SP, Mbalaviele G, Marshak DR, Pittenger MF. 2000. Adult human mesenchymal stem cell differentiation to the osteogenic or adipogenic lineage is regulated by mitogen-activated protein kinase. J Biol Chem 275:9645-9652.
23. Kassem M. 2006. Stem cells: Potential therapy for age-related diseases. Ann NY Acad Sci 1067:436-442.
24. Katagiri T, Yamaguchi A, Komaki M, Abe E, Takahashi N, Ikeda T, Rosen V, Wozney JM, Fujisawa-Sehara A, Suda T. 1994. Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage. J Cell Biol 127:1755-1766.
25. Kimelman N, Pelled G, Gazit Z, Gazit D. 2006. Applications of gene therapy and adult stem cells in bone bioengineering. Regen Med 1:549-561.
26. Lee B, Thirunavukkarasu K, Zhou L, Pastore L, Baldini A, Hecht J, Geoffroy V, Ducy P, Karsenty G. 1997. Missense mutations abolishing DNA binding of the osteoblast-specific transcription factor OSF2/CBFA1 in cleidocranial dysplasia. Nat Genet 16:307-310.
27. Lian JB, Javed A, Zaidi SK, Lengner C, Montecino M, van Wijnen AJ, Stein JL, Stein GS. 2004. Regulatory controls for osteoblast growth and differentiation: Role of Runx/Cbfa/AML factors. Crit Rev Eukaryot Gene Expr 14:1-41.
28. Liu Z,Xu J, Colvin JS, Ornitz DM. 2002. Coordination of chondrogenesis and osteogenesis by fibroblast growth factor 18. Genes Dev 16:859-869.
29. Marie PJ. 2003. Fibroblast growth factor signaling controlling osteoblast differentiation. Gene 316:23-32.
30. Marie PJ. 2008. Transcription factors controlling osteoblastogenesis. Arch Biochem Biophys 473:98-105.
31. Marie PJ, Fromigue O. 2006. Osteogenic differentiation of human marrow-derived mesenchymal stem cells. Regen Med 1:539-548.
32. Martin I, Muraglia A, Campanile G, Cancedda R, Quarto R. 1997. Fibroblast growth factor-2 supports ex vivo expansion and maintenance of osteogenic precursors from human bone marrow. Endocrinology 138:4456-4462.
33. Miraoui H, Oudina K, Petite H, Tanimoto Y, Moriyama K, Marie PJ. 2009. Fibroblast growth factor receptor 2 promotes osteogenic differentiation in mesenchymal cells via ERK1/2 and protein kinase C signaling. J Biol Chem 284:4897-4904.
34. Ohbayashi N, Shibayama M, Kurotaki Y, Imanishi M, Fujimori T, Itoh N, Takada S. 2002. FGF18 is required for normal cell proliferation and differentiation during osteogenesis and chondrogenesis. Genes Dev 16:870-879.
35. Ornitz DM, Marie PJ. 2002. FGF signaling pathways in endochondral and intramembranous bone development and human genetic disease. Genes Dev 16:1446-1465.
36. Phinney DG, Prockop DJ. 2007. Concise review: Mesenchymal stem/multipotent stromal cells: The state of transdifferentiation and modes of tissue repair-current views. Stem Cells 25:2896-2902.
37. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR. 1999. Multilineage potential of adult human mesenchymal stem cells. Science 284:143-147.
38. Pri-Chen S, Pitaru S, Lokiec F, Savion N. 1998. Basic fibroblast growth factor enhances the growth and expression of the osteogenic phenotype of dexamethasone-treated human bone marrow-derived bone-like cells in culture. Bone 23:111-117.
39. Reinhold MI, Naski MC. 2007. Direct interactions of Runx2 and canonical Wnt signaling induce FGF18. J Biol Chem 282:3653-3663.
40. Rickard DJ, Sullivan TA, Shenker BJ, Leboy PS, Kazhdan I. 1994. Induction of rapid osteoblast differentiation in rat bone marrow stromal cell cultures by dexamethasone and BMP-2. Dev Biol 161:218-228.
41. Xiao L, Naganawa T, Obugunde E, Gronowicz G, Ornitz DM, Coffin JD, Hurley MM. 2004. Stat1 controls postnatal bone formation by regulating fibroblast growth factor signaling in osteoblasts. J Biol Chem 279:27743-27752.